A citation-based method for searching scientific literature

Joe Nassour, Tobias T Schmidt, Jan Karlseder. Annu Rev Cancer Biol 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Telomeres and telomerase: three decades of progress.
Jerry W Shay, Woodring E Wright. Nat Rev Genet 2019
208
100

TERT Promoter Mutations and the 8th Edition TNM Classification in Predicting the Survival of Thyroid Cancer Patients.
Jun Park, Sungjoo Lee, Kyunga Kim, Hyunju Park, Chang-Seok Ki, Young Lyun Oh, Jung Hee Shin, Jee Soo Kim, Sun Wook Kim, Jae Hoon Chung,[...]. Cancers (Basel) 2021
5
100

Low frequency of TERT promoter mutations in gastrointestinal stromal tumors (GISTs).
Nathália C Campanella, Ricardo Celestino, Ana Pestana, Cristovam Scapulatempo-Neto, Antonio Talvane de Oliveira, Maria José Brito, António Gouveia, José Manuel Lopes, Denise Peixoto Guimarães, Paula Soares,[...]. Eur J Hum Genet 2015
21
100

Perspectives on ENCODE.
Michael P Snyder, Thomas R Gingeras, Jill E Moore, Zhiping Weng, Mark B Gerstein, Bing Ren, Ross C Hardison, John A Stamatoyannopoulos, Brenton R Graveley, Elise A Feingold,[...]. Nature 2020
41
100

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors.
Jeanette E Eckel-Passow, Daniel H Lachance, Annette M Molinaro, Kyle M Walsh, Paul A Decker, Hugues Sicotte, Melike Pekmezci, Terri Rice, Matt L Kosel, Ivan V Smirnov,[...]. N Engl J Med 2015
990
100

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
198
100

Clinical, environmental and histological distribution of BRAF, NRAS and TERT promoter mutations among patients with cutaneous melanoma: a retrospective study of 563 patients.
E Manrique-Silva, S Rachakonda, D Millán-Esteban, Z García-Casado, C Requena, V Través, R Kumar, E Nagore. Br J Dermatol 2021
7
100

Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target.
Massih Ningarhari, Stefano Caruso, Théo Z Hirsch, Quentin Bayard, Andrea Franconi, Anne-Laure Védie, Bénédicte Noblet, Jean-Frédéric Blanc, Giuliana Amaddeo, Nathalie Ganne,[...]. J Hepatol 2021
9
100

Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.
Ismail Hosen, P Sivaramakrishna Rachakonda, Barbara Heidenreich, Petra J de Verdier, Charlotta Ryk, Gunnar Steineck, Kari Hemminki, Rajiv Kumar. Int J Cancer 2015
60
100

Control of telomerase action at human telomeres.
Dirk Hockemeyer, Kathleen Collins. Nat Struct Mol Biol 2015
74
100

TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.
Sabine Spiegl-Kreinecker, Daniela Lötsch, Katharina Neumayer, Lucia Kastler, Johannes Gojo, Christine Pirker, Josef Pichler, Serge Weis, Rajiv Kumar, Gerald Webersinke,[...]. Neuro Oncol 2018
47
100

Genomic footprints of activated telomere maintenance mechanisms in cancer.
Lina Sieverling, Chen Hong, Sandra D Koser, Philip Ginsbach, Kortine Kleinheinz, Barbara Hutter, Delia M Braun, Isidro Cortés-Ciriano, Ruibin Xi, Rolf Kabbe,[...]. Nat Commun 2020
30
100


Report From the International Society of Urological Pathology (ISUP) Consultation Conference On Molecular Pathology Of Urogenital Cancers. II. Molecular Pathology of Bladder Cancer: Progress and Challenges.
Joshua I Warrick, Margaret A Knowles, Allory Yves, Theo van der Kwast, David J Grignon, Glen Kristiansen, Lars Egevad, Arndt Hartmann, Liang Cheng. Am J Surg Pathol 2020
11
100

Frequency of TERT Promoter Mutations in Prostate Cancer.
Robert Stoehr, Helge Taubert, Ulrike Zinnall, Johannes Giedl, Nadine T Gaisa, Maximilian Burger, Petra Ruemmele, Carolyn D Hurst, Margaret A Knowles, Bernd Wullich,[...]. Pathobiology 2015
28
100

Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation.
Camilla Pilati, Eric Letouzé, Jean-Charles Nault, Sandrine Imbeaud, Anaïs Boulai, Julien Calderaro, Karine Poussin, Andrea Franconi, Gabrielle Couchy, Guillaume Morcrette,[...]. Cancer Cell 2014
164
100

Molecular basis of telomere dysfunction in human genetic diseases.
Grzegorz Sarek, Paulina Marzec, Pol Margalef, Simon J Boulton. Nat Struct Mol Biol 2015
55
100


Apollo contributes to G overhang maintenance and protects leading-end telomeres.
Peng Wu, Megan van Overbeek, Sean Rooney, Titia de Lange. Mol Cell 2010
98
100

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
P Sivaramakrishna Rachakonda, Ismail Hosen, Petra J de Verdier, Mahdi Fallah, Barbara Heidenreich, Charlotta Ryk, N Peter Wiklund, Gunnar Steineck, Dirk Schadendorf, Kari Hemminki,[...]. Proc Natl Acad Sci U S A 2013
217
100

Telomeres in cancer: tumour suppression and genome instability.
John Maciejowski, Titia de Lange. Nat Rev Mol Cell Biol 2017
284
100

TIN2 Functions with TPP1/POT1 To Stimulate Telomerase Processivity.
Alexandra M Pike, Margaret A Strong, John Paul T Ouyang, Carol W Greider. Mol Cell Biol 2019
23
100

Recurrent and functional regulatory mutations in breast cancer.
Esther Rheinbay, Prasanna Parasuraman, Jonna Grimsby, Grace Tiao, Jesse M Engreitz, Jaegil Kim, Michael S Lawrence, Amaro Taylor-Weiner, Sergio Rodriguez-Cuevas, Mara Rosenberg,[...]. Nature 2017
161
100

Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age.
Daniela Lötsch, Bahil Ghanim, Magdalena Laaber, Gabriele Wurm, Serge Weis, Stefan Lenz, Gerald Webersinke, Josef Pichler, Walter Berger, Sabine Spiegl-Kreinecker. Neuro Oncol 2013
48
100

Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication.
Agnel Sfeir, Settapong T Kosiyatrakul, Dirk Hockemeyer, Sheila L MacRae, Jan Karlseder, Carl L Schildkraut, Titia de Lange. Cell 2009
650
100

TERT promoter mutations and telomeres during tumorigenesis.
Franziska K Lorbeer, Dirk Hockemeyer. Curr Opin Genet Dev 2020
16
100

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.
Barbara Heidenreich, P Sivaramakrishna Rachakonda, Ismail Hosen, Florian Volz, Kari Hemminki, Astrid Weyerbrock, Rajiv Kumar. Oncotarget 2015
56
100


Is junk DNA bunk? A critique of ENCODE.
W Ford Doolittle. Proc Natl Acad Sci U S A 2013
212
100

Germline TERT promoter mutations are rare in familial melanoma.
Mark Harland, Mia Petljak, Carla Daniela Robles-Espinoza, Zhihao Ding, Nelleke A Gruis, Remco van Doorn, Karen A Pooley, Alison M Dunning, Lauren G Aoude, Karin A W Wadt,[...]. Fam Cancer 2016
28
100

Frequent DPH3 promoter mutations in skin cancers.
Evgeniya Denisova, Barbara Heidenreich, Eduardo Nagore, P Sivaramakrishna Rachakonda, Ismail Hosen, Ivana Akrap, Víctor Traves, Zaida García-Casado, José Antonio López-Guerrero, Celia Requena,[...]. Oncotarget 2015
38
100

Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation.
Hanlin Zeng, Aparna Jorapur, A Hunter Shain, Ursula E Lang, Rodrigo Torres, Yuntian Zhang, Andrew S McNeal, Thomas Botton, Jue Lin, Matthew Donne,[...]. Cancer Cell 2018
44
100

Telomere shortening is proportional to the size of the G-rich telomeric 3'-overhang.
K E Huffman, S D Levene, V M Tesmer, J W Shay, W E Wright. J Biol Chem 2000
190
100


Human MettL3-MettL14 RNA adenine methyltransferase complex is active on double-stranded DNA containing lesions.
Dan Yu, John R Horton, Jie Yang, Taraneh Hajian, Masoud Vedadi, Cari A Sagum, Mark T Bedford, Robert M Blumenthal, Xing Zhang, Xiaodong Cheng. Nucleic Acids Res 2021
1
100

Telomere length set point regulation in human pluripotent stem cells critically depends on the shelterin protein TPP1.
John M Boyle, Kelsey M Hennick, Samuel G Regalado, Jacob M Vogan, Xiaozhu Zhang, Kathleen Collins, Dirk Hockemeyer. Mol Biol Cell 2020
2
100

Mutations of the BRAF gene in human cancer.
Helen Davies, Graham R Bignell, Charles Cox, Philip Stephens, Sarah Edkins, Sheila Clegg, Jon Teague, Hayley Woffendin, Mathew J Garnett, William Bottomley,[...]. Nature 2002
100

Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene.
S Renaud, D Loukinov, Z Abdullaev, I Guilleret, F T Bosman, V Lobanenkov, J Benhattar. Nucleic Acids Res 2007
135
100

TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.
Linda J Valentijn, Jan Koster, Danny A Zwijnenburg, Nancy E Hasselt, Peter van Sluis, Richard Volckmann, Max M van Noesel, Rani E George, Godelieve A M Tytgat, Jan J Molenaar,[...]. Nat Genet 2015
204
100

Single-cell imaging reveals unexpected heterogeneity of telomerase reverse transcriptase expression across human cancer cell lines.
Teisha J Rowland, Gabrijela Dumbović, Evan P Hass, John L Rinn, Thomas R Cech. Proc Natl Acad Sci U S A 2019
15
100

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
83
100

Raf proteins and cancer: B-Raf is identified as a mutational target.
Kathryn E Mercer, Catrin A Pritchard. Biochim Biophys Acta 2003
359
100

Molecular mechanisms of telomere biology disorders.
Sherilyn Grill, Jayakrishnan Nandakumar. J Biol Chem 2020
7
100

Determinants of telomere length across human tissues.
Kathryn Demanelis, Farzana Jasmine, Lin S Chen, Meytal Chernoff, Lin Tong, Dayana Delgado, Chenan Zhang, Justin Shinkle, Mekala Sabarinathan, Hannah Lin,[...]. Science 2020
59
100

Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup.
Christine Pirker, Agnes Bilecz, Michael Grusch, Thomas Mohr, Barbara Heidenreich, Viktoria Laszlo, Paul Stockhammer, Daniela Lötsch-Gojo, Johannes Gojo, Lisa Gabler,[...]. Clin Cancer Res 2020
6
100

The telomere syndromes.
Mary Armanios, Elizabeth H Blackburn. Nat Rev Genet 2012
572
100

POT1 loss-of-function variants predispose to familial melanoma.
Carla Daniela Robles-Espinoza, Mark Harland, Andrew J Ramsay, Lauren G Aoude, Víctor Quesada, Zhihao Ding, Karen A Pooley, Antonia L Pritchard, Jessamy C Tiffen, Mia Petljak,[...]. Nat Genet 2014
217
100

TERT promoter mutations in melanoma render TERT expression dependent on MAPK pathway activation.
Andrelou F Vallarelli, P Sivaramakrishna Rachakonda, Jocelyne André, Barbara Heidenreich, Laurence Riffaud, Armand Bensussan, Rajiv Kumar, Nicolas Dumaz. Oncotarget 2016
38
100

Oncogenic Braf induces melanocyte senescence and melanoma in mice.
Nathalie Dhomen, Jorge S Reis-Filho, Silvy da Rocha Dias, Robert Hayward, Kay Savage, Veronique Delmas, Lionel Larue, Catrin Pritchard, Richard Marais. Cancer Cell 2009
393
100

TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma.
Klaus G Griewank, Rajmohan Murali, Bastian Schilling, Tobias Schimming, Inga Möller, Iris Moll, Marion Schwamborn, Antje Sucker, Lisa Zimmer, Dirk Schadendorf,[...]. PLoS One 2013
60
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.